Terlipressin
N ° CAS.: 14636-12-5
EINECS: 238-680-8
Formule moléculaire: C52H74N16O15S2
Masse moléculaire: 1227.37
Pureté (CLHP): 98.0%min.
Apparence: poudre blanche
Impureté unique (CLHP): 1.0%maximum
Composition en acides aminés: ±10% de la théorie
Teneur en peptides (N %): >=80.0%
Teneur en eau(Karl Fischer):>=10.0%
Rotation spécifique (20/ré): -95.0~-105.0°(c=1 1%HAc)
Teneur en acétate (PCSI): <=15.0%
MME(ESI): Cohérent
Équilibre de la masse: 95.0~105,0 %
Noter : Qualité pharmaceutique
Stockage: Fermé, dessous 2 ~ 8ºC preservation
Usage : Norepinephrine-resistant septic shock, bleeding esophageal varices, and for the complications of cirrhosis of the liver (esophageal and gastric variceal bleeding, ascites, liver and kidney syndrome) has important significance for the treatment of patients
Terlipressin (trade names Teripress by New Medicon Pharma and Glypressin by Ferring Pharmaceuticals) is an analogue of vasopressin used as a vasoactive drug in the management of hypotension. It has been found to be effective when norepinephrine does not help.
Indications for use include norepinephrine-resistant septic shock and hepatorenal syndrome. En outre, it is used to treat bleeding esophageal varices.
Between the patients with cirrhosis of the liver into the portal circulation of each vein and venous congestion can occur in vascular anastomosis, portal vein pressure rise phenomenon. The most frequently appeared in the azygos vein anastomosis with lower esophageal varices, instant tube.
This product is pressurized prodrug hormone, vasopressin glycyl in injection into the blood after enzymatic hydrolysis in the molecule is produced a continuous low level. The portal venous pressure it generates the desired effect, but the changes of arterial blood pressure than the use of vasopressin after much smaller, and the blood of a few do not increase the fibrinolytic. Push once its role can be maintained for about 4 ~ 6h.
Intravenous injection, 2mg, every 4 ~ 6h again, until the control, use at most 24h. It is not for children.
| Nom du produit |
Terlipressin Acetate |
| N ° CAS. |
14636-12-5 |
| Formule moléculaire |
C52H74N16O15S2 |
| Masse moléculaire |
1227.37 |
| Pureté (CLHP) |
98.0%min |
| Apparence |
poudre blanche |
| Impureté unique (CLHP) |
1.0%maximum |
| Composition en acides aminés |
± 10% de la théorie |
| Teneur en peptides (N %) |
≥ 80.0% |
| Teneur en eau(Karl Fischer) |
≤ 10.0% |
| Rotation spécifique (20/ré) |
-95.0~-105.0° (c=1 1%HAc) |
| Teneur en acétate (PCSI) |
≤ 15.0% |
| Équilibre de la masse |
95.0~105,0 % |
| Noter |
Qualité pharmaceutique |
